CRISPR Therapeutics AG: Form 8-K, filed May 23, 2024
Filed with the SEC on May 23, 2024 and accepted by EDGAR at May 23, 2024, 08:14 ET.
Items reported
- Item 5.02 Departure or appointment of officers or directors
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0000950123-24-005877. Last ingested by Listed: Nov 2, 2026, 20:24 ET. Listed shows no prices and gives no investment advice.